Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Zang

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Briefings in Bioinformatics|July 23, 2021
Supervised clustering of high-dimensional data using regularized mixture modelingWennan Chang, Changlin Wan, Yong Zang, et al.
Pharmaceutical Statistics|October 7, 2020
TSNP: A two-stage nonparametric phase I/II clinical trial design for immunotherapyYan Han, Hao Liu, Sha Cao, et al.
Statistics in Medicine|April 11, 2019
A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modelingYong Zang, Beibei Guo, Yan Han, et al.
Biometrics|August 1, 2020
A Bayesian adaptive phase I/II clinical trial design with late-onset competing risk outcomesYifei Zhang, Sha Cao, Chi Zhang, et al.
Statistical Methods in Medical Research|December 8, 2023
A Bayesian adaptive biomarker stratified phase II randomized clinical trial design for radiotherapies with competing risk survival outcomesJina Park, Wenjing Hu, Ick Hoon Jin, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|February 4, 2006
Dichloro[(3,5-dimethyl-1H-pyrazol-1-yl)methane]zinc(II) and di-mu-chloro-bis{chloro[(3,5-dimethyl-1H-pyrazol-1-yl)methane]cadmium(II)}Mei-Ling Cheng, Hong-Xi Li, Yong Zang, et al.
Transplantation Proceedings|September 16, 2020
Allograft Necrosis in Liver Biopsy Is Predictive for Organ Outcome and Patient SurvivalXin Zhang, Yong Zang, Yifei Zhang, et al.
Pharmaceutical Statistics|June 26, 2024
T3 + 3: 3 + 3 Design With Delayed OutcomesJiaying Guo, Mengyi Lu, Isabella Wan, et al.
Proceedings of Machine Learning Research|August 14, 2023
Bias Aware Probabilistic Boolean Matrix FactorizationChanglin Wan, Pengtao Dang, Tong Zhao, et al.
Clinical Trials (London, England)|January 11, 2024
Adaptive phase I-II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapiesYong Zang, Beibei Guo, Yingjie Qiu, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Briefings in Bioinformatics|July 23, 2021
Supervised clustering of high-dimensional data using regularized mixture modelingWennan Chang, Changlin Wan, Yong Zang, et al.
Pharmaceutical Statistics|October 7, 2020
TSNP: A two-stage nonparametric phase I/II clinical trial design for immunotherapyYan Han, Hao Liu, Sha Cao, et al.
Statistics in Medicine|April 11, 2019
A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modelingYong Zang, Beibei Guo, Yan Han, et al.
Biometrics|August 1, 2020
A Bayesian adaptive phase I/II clinical trial design with late-onset competing risk outcomesYifei Zhang, Sha Cao, Chi Zhang, et al.
Statistical Methods in Medical Research|December 8, 2023
A Bayesian adaptive biomarker stratified phase II randomized clinical trial design for radiotherapies with competing risk survival outcomesJina Park, Wenjing Hu, Ick Hoon Jin, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|February 4, 2006
Dichloro[(3,5-dimethyl-1H-pyrazol-1-yl)methane]zinc(II) and di-mu-chloro-bis{chloro[(3,5-dimethyl-1H-pyrazol-1-yl)methane]cadmium(II)}Mei-Ling Cheng, Hong-Xi Li, Yong Zang, et al.
Transplantation Proceedings|September 16, 2020
Allograft Necrosis in Liver Biopsy Is Predictive for Organ Outcome and Patient SurvivalXin Zhang, Yong Zang, Yifei Zhang, et al.
Pharmaceutical Statistics|June 26, 2024
T3 + 3: 3 + 3 Design With Delayed OutcomesJiaying Guo, Mengyi Lu, Isabella Wan, et al.
Proceedings of Machine Learning Research|August 14, 2023
Bias Aware Probabilistic Boolean Matrix FactorizationChanglin Wan, Pengtao Dang, Tong Zhao, et al.
Clinical Trials (London, England)|January 11, 2024
Adaptive phase I-II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapiesYong Zang, Beibei Guo, Yingjie Qiu, et al.
Pageof 11